California State Teachers Retirement System (CalSTRS)
EIDX

California State Teachers Retirement System (CalSTRS)’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,552
Closed -$2.18M – 3120
2020
Q4 		$2.18M Hold
16,552
– – ﹤0.01% 1592
2020
Q3 		$836K Sell
16,552
-468
-3% -$21K ﹤0.01% 1967
2020
Q2 		$811K Hold
17,020
– – ﹤0.01% 1970
2020
Q1 		$834K Sell
17,020
-225
-1% -$11.5K ﹤0.01% 1777
2019
Q4 		$990K Hold
17,245
– – ﹤0.01% 1976
2019
Q3 		$620K Buy
17,245
+206
+1% +$8.05K ﹤0.01% 2196
2019
Q2 		$530K Sell
17,039
-8,135
-32% -$221K ﹤0.01% 2328
2019
Q1 		$590K Buy
25,174
+13,434
+114% +$216K ﹤0.01% 2236
2018
Q4 		$162K Buy
11,740
+776
+7% +$9.79K ﹤0.01% 2833
2018
Q3 		$109K Buy
+10,964
New +$180K ﹤0.01% 2988

California State Teachers Retirement System (CalSTRS)'s EIDX Position: Q1 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 16,552 shares — an estimated $2.18M sold.

California State Teachers Retirement System (CalSTRS) first reported a position in EIDX in Q3 2018 and held it in 10 quarters. The position peaked at $2.18M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 16,552 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $2.18M.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Eidos Therapeutics, Inc. Common Stock in Q3 2018 and held it in 10 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Eidos Therapeutics, Inc. Common Stock position peaked at $2.18M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2021, filed 18 May 2021.